Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Dec;89(12):1411-5.
doi: 10.1136/heart.89.12.1411.

Angiogenesis, thrombogenesis, endothelial dysfunction and angiographic severity of coronary artery disease

Affiliations

Angiogenesis, thrombogenesis, endothelial dysfunction and angiographic severity of coronary artery disease

N A Chung et al. Heart. 2003 Dec.

Abstract

Background: Thrombogenesis, angiogenesis, and endothelial damage/dysfunction are components in the pathogenesis of atherosclerosis.

Objective: To investigate the relation of these variables to atherosclerotic disease severity and the possible interrelations between the three.

Methods: 111 patients attending for coronary angiography were studied (85 male, 26 female; mean (SD) age, 61.6 (10.0) years). Plasma concentrations of von Willebrand factor (vWf, a marker of endothelial damage/dysfunction), vascular endothelial growth factor (VEGF, associated with angiogenesis), soluble VEGF receptor Flt-1 (sFlt-1), and tissue factor (TF, a key component of coagulation) were measured by an enzyme linked immunosorbent assay. Following angiography, disease severity was assessed by the number of coronary vessels diseased (> 50% stenosis) and by a coronary atheroma score.

Results: All indices were raised in the patients compared with 34 healthy controls except sFlt-1, which was lower in the patients. No significant correlations were found between the coronary atheroma score and values of vWf (Spearman correlations: r = 0.21, p = 0.83), VEGF (r = 0.11, p = 0.27), or TF (r = -0.04, p = 0.68). However, there was an inverse correlation between plasma sFlt-1 and coronary atheroma score (r = -0.19, p = 0.049). The number of vessels diseased had no relation to any marker. Correlations were found between TF and VEGF (r = 0.25, p = 0.008) and between TF and sFlt-1 (r = 0.42, p < 0.001) in the patients.

Conclusions: Despite evidence of abnormal angiogenesis (VEGF and sFlt-1), thrombogenesis (TF), and endothelial damage/dysfunction (vWf) in the patients with coronary artery disease, there was no correlation between VEGF, sFlt-1, vWf, or TF and angiographically defined disease severity.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Donati MB, Falanga A. Pathogenetic mechanisms of thrombosis in malignancy. Acta Haematol 2001;106:18–24. - PubMed
    1. Francis JL. Haemostasis and cancer. Med Lab Sci 1989;46:331–46. - PubMed
    1. Mackman N. Gene targeting in hemostasis. tissue factor. Front Biosci 2001;6:D208–15. - PubMed
    1. Kamat BR, Galli SJ, Barger AC, et al. Neovascularization and coronary atherosclerotic plaque: cinematographic localization and quantitative histologic analysis. Hum Pathol 1987;18:1036–42. - PubMed
    1. Moulton KS. Plaque angiogenesis and atherosclerosis. Curr Atheroscler Rep 2001;3:225–33. - PubMed

Publication types

MeSH terms

Substances